Comparison of the Pathological Effect Between 2 Cycles and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate RC
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
To compare the pathological effect between 2 cycles and 4 cycles of Capox regimen as
neoadjuvant chemotherapy for low/ intermediate risk stage II/III rectal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
West China Hospital
Collaborators:
Chengdu Fifth People's Hospital Sun Yat-sen University The Third Affiliated Hospital of Kunming Medical University The Third People's Hospital of Chengdu